Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Vertex wins OK for cystic fibrosis drug for younger patients

By , Globe Staff

Federal regulators Wednesday approved Vertex’s Orkambi drug to treat children from 6 to 11 years old.

Boston Scientific to buy endoscopy products company for $210m

By , Globe Staff

EndoChoice Holdings is a Georgia-based company that sells products used in endoscopy procecures.

$3b drive to end diseases apt to tap Boston area’s talent

By and , Globe Staff

The effort by Facebook’s founder and his wife will be a huge opportunity for Boston’s biomedical research complex.

Sarepta seeks to raise $225 million in stock sale

By , Globe Staff

Tapping capital markets at an opportune time, Sarepta Therapeutics Inc. said Wednesday it will seek to raise up to $225 million in a stock sale as it moves to launch its first approved drug and finance research and clinical studies of several other treatments.